Medscape

Renal Function, Use of Certain HF Drugs Predict Mortality in CRT-D Patients

May 11, 2005 (New Orleans) — Poor renal function and the nonuse of certain heart failure medications were powerful predictors of early and late mortality in patients receiving cardiac ...
TCTMD

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

MINNEAPOLIS - Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization ...
Medscape

The Effect of CRT and CRT-D on Mortality and Hospitalization: Findings of the COMPANION Trial

The results of COMPANION also demonstrate that CRT or CRT-D, in combination with optimal pharmacologic therapy (OPT), each respectively reduced the rate of death or hospitalization from any cause by ...
Medical Xpress

Upgrade to cardiac resynchronization therapy benefits heart failure patients with pacing

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
MedPage Today

Lives Prolonged for Longtime CRT-D Users With Heart Failure

Eligible heart failure patients with a wide QRS complex spent more time alive after use of a cardiac resynchronization therapy defibrillator (CRT-D) compared with an implantable ...
TCTMD

Upgrading to CRT Has Big Impact on HFrEF Patients With High RV Pacing Burden

AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...
News Medical

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
Nature

Cardiac resynchronization therapy or atrio-biventricular pacing—what should it be called?

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...
Fierce Healthcare

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy ...
EurekAlert!

Upgrade to cardiac resynchronisation therapy benefits heart failure patients with pacing

Amsterdam, Netherlands – 26 Aug 2023: Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodelling ...
Business Wire

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

Quadra Assura MP ™ CRT-D is an investigational device in the U.S and is not commercially approved in the U.S. About St. Jude Medical St. Jude Medical develops medical technology and services that ...